Role of cytokines and chemokines in renal ischemia-reperfusion injury

Drug News and Perspectives

Volumn 15, Issue 8, 2002, Pages 477-482

  Furuichi, Kengo ^a   Wada, Takashi ^a   Yokoyama, Hitoshi ^a   Kobayashi, Ken ichi ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; ENDOTHELIN 1; ERYTHROPOIETIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; OXYGEN; PLATELET DERIVED GROWTH FACTOR; RANTES; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

CELL INFILTRATION; CELL INTERACTION; CONCENTRATION RESPONSE; CYTOKINE PRODUCTION; ENZYME ACTIVITY; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; KIDNEY ISCHEMIA; KIDNEY TUBULE EPITHELIUM; LEUKOCYTE; LYMPHOCYTIC INFILTRATION; OXYGEN CONCENTRATION; PATHOGENESIS; PROTECTION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REPERFUSION INJURY; REVIEW;

EID: 0036826384     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: 10.1358/dnp.2002.15.8.840067     Document Type: Review

References (61)

1. Smith, C.W. Leukocyle-endothelial cell interactions. Semin Hematol 1993, 4: 45-53.
2. Adams, D.H. and Shaw, S. Leukocyte-endothelial interactions and regulation of leukocyte migration. Lancet 1994, 343: 831-6.
3. Segawa, C., Wada, T., Takaeda, M., Furuichi, K., Matsuda, I., Hisada, Y., Ohta, S., Takasawa, K., Takeda, S., Kobayashi, K. and Yokoyama, H. In situ expression and soluble form of P-selectin in human glomerulonephritis. Kidney Int 1997, 52: 1054-63.
4. Weber, C., Kitayama, J. and Springer, T.A. Differential regulation of beta 1 and beta 2 integrin avidity by chemoattractants in eosinophils. Proc Natl Acad Sci USA 1996, 93: 10939-44.
5. Grabovsky, V., Feigelson, S., Chen, C., Bleijs, D.A., Peled, A., Cinamon, G., Baleux, F., Arenzana-Seisdedos, F., Lapidot, T., van Kooyk, Y., Lobb, R.R. and Alon, R. Subsecond induction of alpha4 integrin clustering by immobilized chemokines stimulates leukocyte tethering and rolling on endothelial vascular cell adhesion molecule 1 under flow conditions. J Exp Med 2000, 192: 495-506.
6. Tachimoto, H., Burdick, M.M., Hudson, S.A., Kikuchi, M., Konstantopoulos, K. and Bochner, B.S. CCR3-active chemokines promote rapid detachment of eosinophils from VCAM-1 in vitro. J Immunol 2000, 165: 2748-54.
7. Luu, N.T., Rainger, G.E. and Nash, G.B. Differential ability of exogenous chemotactic agents to disrupt transendothelial migration of flowing neutrophils. J Immunol 2000, 164: 5961-9.
8. Zernecke, A., Weber, K.S., Erwig, L.P., Kluth, D.C., Schroppel, B., Rees, A.J. and Weber, C. Combinatorial model of chemokine involvement in glomeralar monocyte recruitment: Role of CXC chemokine receptor 2 in infiltration during nephroloxic nephritis. J Immunol 2001, 166: 5755-62.
9. Meldrum, K.K., Meldrum, D.R., Hile, K.L., Burnett, A.L. and Harken, A.H. A novel model of ischemia in renal tubular cells which closely parallels in vivo injury. J Surg Res 2001, 99: 288-93.
10. Prodjosudjadi, W., Gerritsma, J.S., Klar-Mohamad, N., Gerritsen, A.F., Bruijin, J.A., Daha, M.R. and van Es, L.A. Production and cytokine-mediated regulation of monocyte chemoattractant protein-1 by human proximal tubular epithelial cells. Kidney Int 1995, 48: 1477-86.
11. Gerritsma, J.S., Hiemstra, P.S., Gerritsen, A.F., Prodjosudjadi, W., Verweij, C.L., Van Es, L.A. and Daha, M.R. Regulation andproduction of IL-8 by human proximal tubular epithelial cells in vitro. Clin Exp Immunol 1996, 103: 289-94.
12. Tang, W.W., Ulich, T.R., Lacey, D.L., Hill, D.C., Kaufman, S.A., Van, G.Y., Tarprey, J.E. and Yee, J.S. Platelet-derived growth factor-BB induces renal tubulointerstitial myofibroblast formation and tubulointerstitial fibrosis. Am J Pathol 1996, 148: 1169-80.
13. Moore, K. J., Wada, T., Barbee, S.D. and Kelley, V.R. Gene transfer of RANTES elicits autoimmune renal injury in MRL-Faslpr mice. Kidney Int 1998, 53: 1631-41.
14. Kramer, B.K., Bucher, M., Sandner, P., Ittner, K.P., Riegger, G.A., Ritthaler, T. and Kurtz, A. Effects of hypoxia on growth factor expression in the rat kidney in vivo. Kidney Int 1997, 51: 444-7.
15. Schlondorff, D., Nelson, P.J., Luckow, B. and Banas, B. Chemokines and renal disease. Kidney Int 1997, 51: 610-21.
16. Nelson, P.J. and Krensky, A.M. Chemokines, lymphocytes and viruses: What goes around, comes around. Curr Opin Immunol 1998, 10: 265-70.
17. Nelson, P.J., Ortiz, B.D., Pattison, J.M. and Krensky, A.M. Identification of a novel regulatory region critical for expression of the RANTES chemokine in activated T lymphocytes. J Immunol 1996, 157: 1139-48.
18. Yasumoto, K., Okamoto, S., Mukaida, N., Murakami, S., Mai, M. and Matsushima, K. Tumor necrosis factor alpha and interferon gamma synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-kappaB-like binding sites of the interleukin 8 gene. J Biol Chem 1992, 267: 22506-11
19. Lenardo, M.J. and Baltimore, D. NF-kappaB: A pleiotropic mediator of inducible and tissue-specific gene control. Cell 1989, 2: 227-9.
20. Mulligan, M.S., Vaporciyan, A.A., Miyasaka, M., Tamatani, T. and Ward, P.A. Donor necrosis factor alpha regulates in vivo intrapulmonary expression of ICAM-1. Am J Pathol 1993, 142: 1739-49.
21. Liu, Y., Cox, S.R., Morita, T. and Kourembanas, S. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Circ Res 1995, 77: 638-43.
22. Huang, E., Arany, Z., Livingston, D.M. and Bunn, H.F. Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its subunit. J Biol Chem 1996, 271: 32253-9.
23. Salceda, S. and Caro, J. Hypoxia-inducible factor 1 (HIF-1) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. J Biol Chem 1997, 272: 22642-7.
24. El Awad, B., Kreft, B., Wolber, E.M., Hellwig-Burgel, T., Metzen, E., Fandrey, J. and Jelkmann, W. Hypoxia and interleukin-1beta stimulate vascular endothelial growth factor production in human proximal tubular cells. Kidney Int 2000, 58: 43-50.
25. Wenger, R.H. and Gassmann, M. Oxygen(es) and the hypoxia-inducible factor-1. Biol Chem 1997, 378: 609-16.
26. Nemoto, T., Yokota, N., Keane, W.F. and Rabb, H. Recombinant erythropoietin rapidly treats anemia in ischemic acute renal failure. Kidney Int 2001, 59: 246-51.
27. Ferrara, N. and Davis-Smyth, T. The biology of vascular endothelial growth factor. Endocr Rev 1997, 18: 4-25.
28. Sato, W., Kadomatsu, K., Yuzawa, Y., Muramatsu, H., Hotta, N., Matsuo, S. and Muramatsu, T. Midkine is involved in neutrophil infiltration into the tubulointerstitium in ischemic renal injury. J Immunol 2001 167: 3463-9.
29. Segerer, S., Nelson, P.J. and Schlondorff, Chemokines, chemokine receptors, and renal disease: From basic science to pathophysiologic and therapeutic studies. J Am Soc Nephrol 2000, 11: 152-76.
30. Pascual, M., Theruvath, T., Kawai, T., Tolkoff-Rubin, N. and Cosimi, A.B. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 2002, 346: 580-90.
31. Grone, H.J., Weber, C., Weber, K.S., Grone, E.F., Rabelink, T., Klier, C.M., Wells, T.N., Proudfood, A.E., Schlondorff, D. and Nelson, P.J. Met-RANTES reduces vascular and tubular damage during acute renal transplant rejection: Blocking monocyte arrest and recruitment. FASEB J 1999, 13: 1371-83.
32. Nagano, H., Nadeau, K.C., Takada, M., Kusaka, M. and Tilney, N.L. Sequential cellular and molecular kinetics in acutely rejecting renal allografts in rats. Transplantation 1997, 63: 1101-8.
33. Azuma, H., Takahara, S., Matsumoto, K., Ichimaru, N., Wang, J.D., Moriyama, T., Waaga, A.M., Kitamura, M., Otsuki, Y., Okuyama, A., Katsuoka, Y., Chandraker, A., Sayegh, M.H. and Nakamura T. Hepatocyte growth factor prevents the development of chronic allograft nephropathy in rats. J Am Soc Nephrol 2001, 12: 1280-92.
34. Pattison, J., Nelson, P.J., Huie, P., von Leuttichau, I., Farshid, G., Sibley, R.K. and Krensky, A.M. RANTES chemokine expression in cell-mediated transplant rejection of the kidney. Lancet 1994, 343: 209-11.
35. Robertson, H., Wheeler, J., Morley, A.R., Booth, T.A., Talbot, D. and Kirby, J.A. Betachemokine expression and distribution in paraffin-embedded transplant renal biopsy sections: Analysis by scanning laser confocal microscopy. Histochem Cell Biol 1998, 110: 207-13.
36. Robertson, H., Morley, A.R., Talbot, D., Callanan, K. and Kirby, J.A. Renal allograft rejection: Beta-chemokine involvement in the development of tubulitis. Transplantation 2000, 69: 684-7.
37. Strehlau, J., Pavlakis, M., Lipman, M., Shapiro, M., Vasconcellos, L., Harmon, W. and Strom, T.B. Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation. Proc Natl Acad Sci USA 1997, 94: 695-700.
38. Grandaliano, G., Gesualdo, L., Ranieri, E., Monno, R., Stallone, G. and Schena, F.P. Monocyte chemotactic peptide-1 expression and monocyte infiltration in acute renal transplant rejection. Transplantation 1997, 63: 414-20.
39. Wada, T., Tomosugi, N., Naito, T., Yokoyama, H., Kobayashi, K., Harada, A., Mukaida, N. and Matsushima, K. Prevention of proteinuria by the administration of anti-interleukin 8 antibody in experimental acute immune complex-induced glomerulonephritis. J Exp Med 1994, 180: 1135-40.
40. Wada, T., Yokoyama, H., Furuichi, K., Kobayashi, K.I., Harada, K., Naruto, M., Su, S.B., Akiyama, M., Mukaida, N. and Matsushima, K. Intervention of crescentic glomerulonephritis by antibodies to monocyte chemotactic and activating factor (MCAF/MCP-1). FASEB J 1996, 10: 1418-25.
41. Wada, T., Yokoyama, H., Matsushima, K. and Kobayashi, K. Chemokines in renal diseases. Int Immunopharmacol 2001, 1: 637-45.
42. Cascieri, M.A. and Springer, M.S. The chemokine/chemokine-receptor family: Potential and progress for therapeutic intervention. Curr Opin Chem Biol 2000, 4: 420-7.
43. Proudfoot, A.E. Chemokine receptors: Multifäceted therapeutic targets. Nat Rev Immunol 2002, 2: 106-15.
44. Furuichi, K. Wada, T., Iwata, Y., Sakai, N., Yoshimoto, K., Kobayashi, K., Mukaida, N., Matsushima, K. and Yokoyama, H. Administration of FR167653, a new anti-inflammatory compound, prevents renal ischaemia/reperfusion injury in mice. Nephrol Dial Transplant 2002, 17: 399-407.
45. Wada, T., Furuichi, K., Sakai, N., Hisada, Y., Kobayashi, K., Mukaida, N., Tomosugi, N., Matsushima, K. and Yokoyama, H. Involvement of p38 mitogen-activated protein kinase followed by chemokine expression in crescentic glomerulonephritis. Am J Kidney Dis 2001, 38: 1169-77.
46. Wada, T., Furuichi, K., Sakai, N., Iwata, Y., Yoshimoto, K., Shimizu, M., Kobayashi, K., Mukaida, N., Matsushima, K. and Yokoyama, H. A new anti-inflammatory compound, FRl67653, ameliorates crescentic glomerulonephritis in Wistar-Kyoto rats. J Am Soc Nephrol 2000, 11: 1534-41.
47. Xie, Y., Sakatsume, M., Nishi, S., Narita, I., Arakawa, M. and Gejyo, F. Expression, roles, receptors, and regulation of osteopontin in the kidney. Kidney Int 2001, 60: 1645-57.
48. Chiao, H., Kohda, Y., McLeroy, P., Craig, L., Housini, I. and Star, R.A. Alpha-melanocyte-stimulating hormone protects against renal injury after ischemia in mice and rats. J Clin Invest 1997, 99: 1165-72.
49. Goes, N., Urmson, J., Vincent, D., Ramassar, V. and Halloran, P.F. Effect of recombinant human insulin-like growth factor-1 on the inflammatory response to acute renal injury. J Am Soc Nephrol 1996, 7: 710-20
50. Miller, S.B., Martin, D.R., Kissane, J. and Hammerman, M.R. Hepatocyte growth factor accelerates recovery from acute ischemic renal injury in rat. Am J Physiol 1994, 266(1 Pt 2): F129-34.
51. Haq, M., Norman, J., Saba, S.R., Ramirez, G., Rabb, H. Role of IL-1 in renal ischemic reperfusion injury. J Am Soc Nephrol 1998, 9: 614-9.
52. Kelly, K.J. Williams, W.W. Jr., Colvin, R.B. et al. Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J Clin Invest 1996, 97: 1056-63.
53. Singbartl, K., Green, S.A., Ley, K. Blocking P-selectin protects from ischemia/reperfusion-induced acute renal failure. FASEB J 2000, 14: 48-54.
54. Rabb, H., Ramirez, G., Saba, S.R., Reynolds, D., Xu, J., Flavell, R., Antonia, S. Renal ischemic-reperfusion injury in L-selectin-deficient mice. Am J Physiol 1996, 271: F408-13.
55. Miura, M., Fu, X., Zhang, Q.W., Remick, D.G., Fairchild, R.L. Neutralization of Gro alpha and macrophage inflammatory protein-2 attenuates renal ischemia/reperfusion injury. Am J Pathol 2001, 159: 2137-45.
56. Torras, J., Cruzado, J.M., Riera, M. et al. Long-term protective effect of UR-12670 after warm renal ischemia in uninephrectomized rats. Kidney Int 1999, 56: 1798-808.
57. Kusumoto, K., Kubo, K., Kandori, H. et al. Effects of a new endothelin antagonist, TAK-044, on post-ischemic acute renal failure in rats. Life Sci 1994, 55: 301-10.
58. Kelly, K.J., Williams, W.W. Jr., Colvin, R.B., Bonventre, J.V. Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury. Proc Natl Acad Sci USA 1994, 91: 812-6.
59. Singbartl, K., Ley, K. Protection from ischemia-reperfusion induced severe acute renal failure by blocking E-selectin. Crit Care Med 2000, 28: 2507-14.
60. Martin, X., Da Silva, M., Virieux, S.R. et al. Protective effect of an anti-LFA 1 monoclonal antibody (odulimomab) on renal damage due lo ischemia and kidney auto-transplantation. Transplant Proc 2000, 32: 481.
61. Tajra, L.C., Martin, X., Margonari, J. et al. in vivo effects of monoclonal antibodies against rat beta(2) integrins on kidney ischemia-reperfusion injury. J Surg Res 1999, 87: 32-8.